ACRS
Aclaris Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$3.54
+0.03 ▲ +0.85%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$3.54
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -0.53 | Insider Own | 14.83% | Shs Outstand | 0.12B | Perf Week | 15.69% |
| Market Cap | 0.43B | Forward P/E | - | EPS next Y | -6.77% | Insider Trans | - | Shs Float | 0.10B | Perf Month | 4.42% |
| Enterprise Value | 0.34B | PEG | - | EPS next Q | -0.16 | Inst Own | 58.9% | Short Float | 4.63% | Perf Quarter | 8.26% |
| Income | -0.06B | P/S | 54.52 | EPS this Y | -20.75% | Inst Trans | -3.25% | Short Ratio | 2.12 | Perf Half Y | 79.7% |
| Sales | 0.01B | P/B | 4.14 | EPS next 5Y | -12.87% | ROA | -34.1% | Short Interest | 4.76M | Perf YTD | 17.61% |
| Book/sh | 0.86 | P/C | 4.7 | EPS past 3/5Y | 26.48% 15.08% | ROE | -50.2% | 52W High | -27.61% ($4.89) | Perf Year | 126.92% |
| Cash/sh | 0.75 | P/FCF | - | Sales past 3/5Y | -35.93% 3.84% | ROIC | -62.04% | 52W Low | 237.14% ($1.05) | Perf 3Y | -57.14% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 64.96% | Gross Margin | 6.93% | Volatility(W/M) | 9.33% 7.6% | Perf 5Y | -85.96% |
| Dividend TTM | - | EV/Sales | 43.2 | Sales Y/Y TTM | -58.2% | Oper. Margin | -943.97% | ATR (14) | 0.27 | Perf 10Y | -78.98% |
| Dividend Ex-Date | - | Quick Ratio | 3.36 | EPS Q/Q | 84.07% | Profit Margin | -829.58% | RSI (14) | 56.69 | Recom | 1.2 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.36 | Sales Q/Q | -85.94% | SMA20 | 8.77% ($3.25) | Beta | 0.78 | Target Price | $8.94 |
| Payout | - | Debt/Eq | 0.02 | Earnings | 2000000 | SMA50 | 7.03% ($3.31) | Rel Volume | 0.4 | Prev Close | $3.51 |
| Employees | 73 | LT Debt/Eq | 0.02 | EPS/Sales Surpr. | -10.57% -37.47% | SMA200 | 50.68% ($2.35) | Avg Volume(3M) | 2.25M | Price | $3.54 |
| IPO | 2015/10/7 | Option/Short | Yes/Yes | Trades | 4762 | Volume | 899,617 | Change | 0.85% |
뉴스 로딩 중...